TNF and inflammatory bowel disease: <h4>Background and aims</h4>Despite potential benefits of anti-TNF proactive therapeutic drug monitoring (pTDM), few randomized controlled trials have assessed the impact of maintenance therapy in children with inflammatory bowel disease.<h4>Methods</h4>This single-center randomized controlled trial assessed pTDM in pediatric patients receiving infliximab maintenance therapy.